Literature DB >> 27699603

C-Terminal Binding Protein is Involved in Promoting to the Carcinogenesis of Human Glioma.

Bo Liu1, Gloria Di2.   

Abstract

C-terminal binding protein (CtBP) is responsible for regulating the pathogenesis of a lot of cancer types. However, whether CtBP1/2 is involved in regulating the growth and development of human glioma is still obscure. In the present study presented here, our results firstly reveal that CtBP1/2 deficiency, induced by siRNA interference, disrupts the functional integrity of the MRN complex that is responsible for DNA repair in human glioma cells. The dysfunction of the MRN complex further contributes to the up-regulation of ATM and Rad3-related kinase (ATR) and Chk1 signaling pathway, which inhibits cell cycle progression mediated by CDK2, preparing for the initiation of DNA repair. Under the condition of hypoxia, hypoxia-inducible factor-1α (HIF-1α) can be directly regulated by CDK2 on protein level, playing coordinately regulatory role in the carcinogenesis of human glioma cells. Overall, our findings reveal that CtBP1/2 is essential to promote to human glioma cell growth through maintaining the DNA stability regulated by the MRN/ATR/Chk1/CDK2/HIF-1α signaling pathway.

Entities:  

Keywords:  Cell cycle; CtBP; DNA damage; Oncogenesis; Transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 27699603     DOI: 10.1007/s12035-016-0159-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  37 in total

1.  Structure-guided design of a high affinity inhibitor to human CtBP.

Authors:  Brendan J Hilbert; Benjamin L Morris; Keith C Ellis; Janet L Paulsen; Celia A Schiffer; Steven R Grossman; William E Royer
Journal:  ACS Chem Biol       Date:  2015-01-30       Impact factor: 5.100

2.  C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs.

Authors:  Madeleine Grooteclaes; Quinn Deveraux; Jeffrey Hildebrand; Qinghong Zhang; Richard H Goodman; Steven M Frisch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

3.  Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.

Authors:  Guoyu Huang; Jun Cheng; Fudong Yu; Xisheng Liu; Chenwei Yuan; Chenchen Liu; Xiaolei Chen; Zhihai Peng
Journal:  Oncol Rep       Date:  2016-03-17       Impact factor: 3.906

4.  Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.

Authors:  Wei-Wen Sung; Yi-Chih Chu; Peir-Rong Chen; Ming-Hui Liao; Jeng-Woei Lee
Journal:  Cancer Lett       Date:  2016-08-24       Impact factor: 8.679

5.  Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.

Authors:  Xueni Liu; Elphire Ehmed; Boyao Li; Jianming Dou; Xiaojing Qiao; Wenyong Jiang; Xi Yang; Shouyi Qiao; Yanhua Wu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

6.  Hypo/unmethylated promoter status of Cdk2 gene correlates with its over-expression in ovarian cancer in north Indian population.

Authors:  A Kanwal; M Kaur; A Singh; S Gupta; M Sachan
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2016-01-22       Impact factor: 1.770

7.  Analysis of Residual DSBs in Ataxia-Telangiectasia Lymphoblast Cells Initiating Apoptosis.

Authors:  Teresa Anglada; Mariona Terradas; Laia Hernández; Anna Genescà; Marta Martín
Journal:  Biomed Res Int       Date:  2016-01-06       Impact factor: 3.411

8.  ATR- and ATM-Mediated DNA Damage Response Is Dependent on Excision Repair Assembly during G1 but Not in S Phase of Cell Cycle.

Authors:  Alo Ray; Chessica Blevins; Gulzar Wani; Altaf A Wani
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

9.  LXY6090 - a novel manassantin A derivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibition.

Authors:  Fangfang Lai; Qian Liu; Xiaoyu Liu; Ming Ji; Ping Xie; Xiaoguang Chen
Journal:  Onco Targets Ther       Date:  2016-06-24       Impact factor: 4.147

10.  Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer.

Authors:  Gary Beale; Emma J Haagensen; Huw D Thomas; Lan-Zhen Wang; Charlotte H Revill; Sara L Payne; Bernard T Golding; Ian R Hardcastle; David R Newell; Roger J Griffin; Celine Cano
Journal:  Br J Cancer       Date:  2016-08-16       Impact factor: 7.640

View more
  1 in total

Review 1.  CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.

Authors:  M Michael Dcona; Benjamin L Morris; Keith C Ellis; Steven R Grossman
Journal:  Cancer Biol Ther       Date:  2017-05-22       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.